Avricore Health Inc.
AVCRF
$0.03
$0.0122.11%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -96.87% | -97.29% | -63.74% | 1.98% | 23.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -96.87% | -97.29% | -63.74% | 1.98% | 23.27% |
| Cost of Revenue | -88.25% | -88.74% | -87.10% | -5.30% | 8.11% |
| Gross Profit | -111.98% | -112.84% | -32.90% | 14.32% | 63.32% |
| SG&A Expenses | -46.54% | 32.77% | 26.82% | 15.50% | 9.44% |
| Depreciation & Amortization | 100.00% | 60.00% | 60.00% | 75.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -69.95% | -51.34% | -50.19% | 1.64% | 8.68% |
| Operating Income | -136.90% | -727.55% | -135.53% | 7.61% | 43.06% |
| Income Before Tax | -109.75% | -940.00% | -143.12% | -1,262.10% | 38.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -109.75% | -940.00% | -143.12% | -1,262.10% | 38.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -109.75% | -940.00% | -143.12% | -1,262.10% | 38.21% |
| EBIT | -136.90% | -727.55% | -135.53% | 7.61% | 43.06% |
| EBITDA | -714.04% | -321.27% | -109.27% | -5.69% | 73.60% |
| EPS Basic | -107.69% | -925.00% | -138.46% | -1,350.00% | 38.10% |
| Normalized Basic EPS | -112.50% | -1,100.00% | -142.86% | 33.33% | 38.46% |
| EPS Diluted | -107.69% | -925.00% | -138.46% | -- | 38.10% |
| Normalized Diluted EPS | -112.50% | -1,100.00% | -142.86% | 33.33% | 38.46% |
| Average Basic Shares Outstanding | 0.89% | 1.42% | 1.55% | 1.58% | 0.76% |
| Average Diluted Shares Outstanding | 0.89% | -4.09% | 1.55% | 1.58% | 0.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |